These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16996384)

  • 1. The business of addiction treatment: A research agenda.
    Kimberly JR; McLellan AT
    J Subst Abuse Treat; 2006 Oct; 31(3):213-9. PubMed ID: 16996384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving consistency and quality of service delivery: implications for the addiction treatment field.
    Knott AM; Corredoira R; Kimberly J
    J Subst Abuse Treat; 2008 Sep; 35(2):99-108. PubMed ID: 18082996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Industry evolution through consolidation: Implications for addiction treatment.
    Corredoira RA; Kimberly JR
    J Subst Abuse Treat; 2006 Oct; 31(3):255-65. PubMed ID: 16996388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does America spend enough on addiction treatment? Results from public opinion surveys.
    French MT; Homer JF; Nielsen AL
    J Subst Abuse Treat; 2006 Oct; 31(3):245-54. PubMed ID: 16996387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blending addiction research and practice: strategies for technology transfer.
    Condon TP; Miner LL; Balmer CW; Pintello D
    J Subst Abuse Treat; 2008 Sep; 35(2):156-60. PubMed ID: 18337054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
    Cartwright WS
    J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of organization and management in substance abuse treatment: Review and roadmap.
    D'Aunno T
    J Subst Abuse Treat; 2006 Oct; 31(3):221-33. PubMed ID: 16996385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the importance of organizational and system variables on addiction treatment services within criminal justice settings.
    McCarty D; Chandler RK
    Drug Alcohol Depend; 2009 Aug; 103 Suppl 1():S91-3. PubMed ID: 19356862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction providers. Surviving isn't enough.
    Enos G
    Behav Healthc Tomorrow; 2002 Apr; 11(2):SR36-8. PubMed ID: 11963691
    [No Abstract]   [Full Text] [Related]  

  • 11. Declining services for the chemically dependent.
    Blansfield HN
    Conn Med; 1995 Jun; 59(6):369-70. PubMed ID: 7648857
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between substance user treatment and 12-step fellowships: current knowledge and research questions.
    Magura S
    Subst Use Misuse; 2007; 42(2-3):343-60. PubMed ID: 17558934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection methods of the drug-addiction and alcoholism treatment programme of the Spanish National Railway Company (RENFE).
    Cabrero E; Gómez-Acebo A; García-Alcázar I; Luna JD; Luna A
    Med Lav; 2003; 94(4):364-73. PubMed ID: 14526495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving drug addiction treatment in China.
    Tang YL; Hao W
    Addiction; 2007 Jul; 102(7):1057-63. PubMed ID: 17567394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How many people need substance abuse treatment in North Carolina and how much does it cost?
    McCarthy P; Kissling G; Dirkers J
    N C Med J; 1993 May; 54(5):209-12. PubMed ID: 8389988
    [No Abstract]   [Full Text] [Related]  

  • 16. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues for sustainability of non-government organisations in the alcohol and other drugs sector.
    Spooner C; Dadich A
    Drug Alcohol Rev; 2010 Jan; 29(1):47-52. PubMed ID: 20078682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assessment of cost-benefit analysis in integration projects on drug addiction].
    Ates T; Langer B; Erbas B; Tretter F; Wehner B
    Gesundheitswesen; 2005 Feb; 67(2):159-62. PubMed ID: 15747208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse treatment evolves: a follow-up.
    Spath P
    Hosp Peer Rev; 1997 Sep; 22(9):132-4. PubMed ID: 10173140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.